NervGen Pharma Corp Working Capital to Net Assets Ratio
NervGen Pharma Corp working capital to net assets ratio. NervGen Pharma Corp (NGEN) has a Working Capital to Net Assets ratio of 114.4% as of September 2025. Working capital of CA$-3.36 Million (current assets of CA$12.65 Million minus current liabilities of CA$16.02 Million) is measured against net assets of CA$-2.94 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check NGEN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of NervGen Pharma Corp (2017–2024)
Working capital to net assets ratio of NervGen Pharma Corp from 2017 to 2024. This chart shows how NervGen Pharma Corp's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 114.4%, reflecting working capital of CA$-3.36 Million against net assets of CA$-2.94 Million CAD. See NervGen Pharma Corp defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
NervGen Pharma Corp Working Capital to Net Assets Ratio by Year (2017–2024)
NervGen Pharma Corp working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for NervGen Pharma Corp from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NervGen Pharma Corp total assets.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 82.0% | CA$2.11 Million | CA$2.58 Million | CA$19.01 Million | CA$16.90 Million | ▼ -48.7 pp |
| 2023 | 130.6% | CA$-2.62 Million | CA$-2.01 Million | CA$12.52 Million | CA$15.14 Million | ▲ +34.5 pp |
| 2022 | 96.1% | CA$12.93 Million | CA$13.46 Million | CA$23.15 Million | CA$10.22 Million | ▼ -1.1 pp |
| 2021 | 97.2% | CA$16.34 Million | CA$16.82 Million | CA$17.42 Million | CA$1.08 Million | ▲ +5.2 pp |
| 2020 | 92.0% | CA$5.45 Million | CA$5.92 Million | CA$6.20 Million | CA$755.07K | ▲ +0.7 pp |
| 2019 | 91.3% | CA$5.33 Million | CA$5.84 Million | CA$6.26 Million | CA$923.95K | ▲ +7.7 pp |
| 2018 | 83.6% | CA$2.10 Million | CA$2.51 Million | CA$2.55 Million | CA$448.88K | ▼ -721.2 pp |
| 2017 | 804.7% | CA$-95.06K | CA$-11.81K | CA$0.00 | CA$95.06K | — |